However, emerging evidence suggests that polyphenols exert a downregulatory effect on intestinal FXR-FGF15 signaling by modulating the composition of gut microbiota, particularly those involved in bile acid metabolism, in the context of metabolic diseases [28,29,30]. The gene discussed is NR1H4; the disease is metabolic disease.